Adrian Duncan

Views & Analysis

As the world of medicine continues to deal with the impact of the COVID-19 pandemic, clinicians are moving to digital solutions.

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.